A prospective safety study of allergen immunotherapy in daily clinical practice.
Iglesias-Cadarso
A
A
Servicio de Alergia, Centro de Especialidades de Argüelles, Hospital Puerta de Hierro, C/Quintana 11, 28008 Madrid, Spain. aiglesiasc@meditex.es
Hernández-Weigand
P
P
Reaño
M
M
Herrera
I
I
Sánchez-Morillas
L
L
Pérez-Pimiento
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000486:Allergy and Immunology / Q000458:organization & administration; D000707:Anaphylaxis / Q000453:epidemiology / Q000209:etiology*; D000799:Angioedema / Q000453:epidemiology / Q000209:etiology; D001249:Asthma / Q000453:epidemiology / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000453:epidemiology / Q000209:etiology; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D004306:Dose-Response Relationship, Immunologic; D004485:Eczema / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012221:Rhinitis, Allergic, Perennial / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D014581:Urticaria / Q000453:epidemiology / Q000209:etiology